Somatostatin Receptor Type 2 (SSTR2) in Bronchopulmonary Carcinoids
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Rugge M, Fassan M, Clemente R, Rizzardi G, Giacomelli L, Pennelli G
. Bronchopulmonary carcinoid: phenotype and long-term outcome in a single-institution series of Italian patients. Clin Cancer Res. 2008; 14(1):149-54.
DOI: 10.1158/1078-0432.CCR-07-1631.
View
2.
Volante M, Brizzi M, Faggiano A, La Rosa S, Rapa I, Ferrero A
. Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy. Mod Pathol. 2007; 20(11):1172-82.
DOI: 10.1038/modpathol.3800954.
View
3.
Righi L, Volante M, Tavaglione V, Bille A, Daniele L, Angusti T
. Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 'clinically aggressive' cases. Ann Oncol. 2009; 21(3):548-555.
DOI: 10.1093/annonc/mdp334.
View
4.
Papotti M, Croce S, Bello M, Bongiovanni M, Allia E, Schindler M
. Expression of somatostatin receptor types 2, 3 and 5 in biopsies and surgical specimens of human lung tumours. Correlation with preoperative octreotide scintigraphy. Virchows Arch. 2002; 439(6):787-97.
DOI: 10.1007/s004280100494.
View
5.
Papotti M, Croce S, Macri L, Funaro A, Pecchioni C, Schindler M
. Correlative immunohistochemical and reverse transcriptase polymerase chain reaction analysis of somatostatin receptor type 2 in neuroendocrine tumors of the lung. Diagn Mol Pathol. 2000; 9(1):47-57.
DOI: 10.1097/00019606-200003000-00008.
View